ST. JAMES SURGERY
GAINS LANE, DEVIZES
CKD 5
The percentage of patients on the CKD register with hypertension and proteinuria who are treated with an angiotensin coverting enzyme inhibitor (ACE-I) or angiotensin receptor blocker (AEB) (unless a contraindication or side effects are recorded)
| Indicator | Year | Numerator | Denominator | Ratio | Centile |
|---|---|---|---|---|---|
| CKD 4 | 2007 | 98 | 103 | 95.1% | |
| CKD 4 | 2008 | 100 | 122 | 82.0% | |
| CKD 5 | 2009 | 40 | 48 | 83.3% | |
| CKD 5 | 2010 | 20 | 23 | 87.0% | |
| CKD 5 | 2011 | 23 | 26 | 88.5% | |
| CKD 5 | 2012 | 22 | 25 | 88.0% | |
| CKD 5 | 2013 | 21 | 23 | 91.3% | |
| CKD003 | 2014 | 36 | 38 | 94.7% | |
| CKD003 | 2015 | 45 | 49 | 91.8% | |
| NM84 | 2016 | 50 | 60 | 83.3% | |
| NM84 | 2017 | 51 | 65 | 78.5% | |
| NM84 | 2018 | 52 | 69 | 75.4% | |
| NM84 | 2019 | 37 | 55 | 67.3% | |
| NM84 | 2020 | 35 | 50 | 70.0% | |
| NM84 | 2022 | 36 | 46 | 78.3% |
